Literature DB >> 11060252

[Effect of the use of echoenhancers on interobserver variability in dobutamine stress echocardiography].

J L Zamorano1, V Sánchez, C Almería, V Serra, J L Rodrigo, L Sánchez-Harguindey.   

Abstract

INTRODUCTION: Dobutamine stress echocardiography is an accurate technique for the noninvasive diagnosis of coronary artery disease. However, interobserver variability is an important limitation of stress echocardiography. Image quality and echocardiographer experience have been described to influence interobserver agreement. AIM: The aim of this study was to determine whether use of contrast agents during dobutamine stress echocardiography improves the agreement between an experienced and a unexperienced observer, and if learning period would be influenced by the use of contrast.
METHODS: Two blind observers interpreted all the studies: one experienced echocardiographer (A) and one unexperienced observer (B) in this technique. The contrast agent Levovist/Levograf 2.5 g was administered by two bolus (at rest and at peak stress). In all cases, second harmonic imaging and stress digitalisation packs were used. The kappa test was used to determine interobserver agreement.
RESULTS: Fifty-two unselected consecutive studies in 51 patients were analyzed. Twenty-two studies were performed with contrast. The agreement between the experienced and the unexperienced observer was Kappa 0.58 and 0.52, with and without the use of contrast, with no statistically significant difference being archived.
CONCLUSIONS: The routine use of contrast provides better although not significant, interobserver agreement. However, this improvement is not sufficient to substitute specific training.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060252

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  1 in total

1.  Contrast agents provide a faster learning curve in dipyridamole stress echocardiography.

Authors:  Jose Zamorano; Violeta Sánchez; Raúl Moreno; Carlos Almería; Jose Rodrigo; Viviana Serra; Luis Azcona; Adalia Aubele; Luis Mataix; Luis Sánchez-Harguindey
Journal:  Int J Cardiovasc Imaging       Date:  2002-12       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.